Trader Brian Jones on Twitter: "7:12 am ET Helius Medical Technologies, Inc. Announces FDA Has Granted PoNS Device Breakthrough Device Designation For Treatment Of Gait Deficits Due To Symptoms Of Multiple Sclerosis(Benzinga)" / Twitter

7:12 am ET Helius Medical Technologies, Inc. Announces FDA Has Granted PoNS Device Breakthrough Device Designation For Treatment Of Gait Deficits Due To Symptoms Of Multiple Sclerosis(Benzinga)